Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I am really looking forward to the CC.
It will be very interesting ...
MMRF a rare life changer stock Multi billion dollar company in the making. Exponential gains ahead. Currently near 50m cap. The very best management team I ever seen assembled in penny land. Revenues will be residual and represent organic
growth a cancellation rate of only 1%
They have developed the most advanced Electronic medical records tech in their peer group and are launching massive deals worldwide
From Microsoft’s top executive to NASA Administrator , Former House Minority Leader , Former Congressman, NASA Astronaut, political figures, and a CEO that’s a wealthy successful businessman that won white house humanitarian awards and took a 50m cap company to billion status before he resigned
MMRF has working partnerships and or agreements with Kodak, Unis China, Google Health, sanofi-aventis, Nihilent Technologies
MMRF Signs Global contract with Chartis who has 40m clients in 160 countries worldwide. MMRF tech will be embed in current policy holders they don’t have to sign up. CEO currently on a global trip launching the deal in many countries
http://finance.yahoo.com/news/MMR-Information-Systems-Inc-iw-2121287118.html?x=0&.v=1
MMRF predicted MMRPro implementation in China with Unis-Tonghe by 3rd quarter this year
http://ih.advfn.com/p.php?pid=nmona&article=40425772&symbol=USBB%3AMMRF
Chartis released this very same PR themselves
http://www.chartisinsurance.com/ncglobalweb/internet/US/en/files/PR_MMR_04-08-10_tcm295-255477.pdf
This one deal alone can be worth 100's of millions many more of its kind expected
MMRF negotiated a deal to buy 1000 scanners coming from Kodak which represent 22k sale per (22m)once its all setup and sold . Company has projected an additional1m individuals to sign up this year alone for online medical records
MMR Information Systems, Inc. Taps Into Trillion Dollar Latino Market
http://finance.yahoo.com/news/MMR-Information-Systems-Inc-iw-1869373328.html?x=0&.v=1
Company still owns its bio tech assets it inherited through a reverse merger
140m was put into this tech and it went to stage 3 trials
MMR Information Systems and sanofi-aventis Enter Into Agreement Regarding Anti-CD20 Monoclonal Antibodies
http://finance.yahoo.com/news/MMR-Information-Systems-and-iw-3085022759.html?x=0&.v=1
MMRF a rare life changer stock Multi billion dollar company in the making. Exponential gains ahead. Currently near 50m cap. The very best management team I ever seen assembled in penny land. Revenues will be residual and represent organic
growth a cancellation rate of only 1%
They have developed the most advanced Electronic medical records tech in their peer group and are launching massive deals worldwide
From Microsoft’s top executive to NASA Administrator , Former House Minority Leader , Former Congressman, NASA Astronaut, political figures, and a CEO that’s a wealthy successful businessman that won white house humanitarian awards and took a 50m cap company to billion status before he resigned
MMRF has working partnerships and or agreements with Kodak, Unis China, Google Health, sanofi-aventis, Nihilent Technologies
MMRF Signs Global contract with Chartis who has 40m clients in 160 countries worldwide. MMRF tech will be embed in current policy holders they don’t have to sign up. CEO currently on a global trip launching the deal in many countries
http://finance.yahoo.com/news/MMR-Information-Systems-Inc-iw-2121287118.html?x=0&.v=1
MMRF predicted MMRPro implementation in China with Unis-Tonghe by 3rd quarter this year
http://ih.advfn.com/p.php?pid=nmona&article=40425772&symbol=USBB%3AMMRF
Chartis released this very same PR themselves
http://www.chartisinsurance.com/ncglobalweb/internet/US/en/files/PR_MMR_04-08-10_tcm295-255477.pdf
This one deal alone can be worth 100's of millions many more of its kind expected
MMRF negotiated a deal to buy 1000 scanners coming from Kodak which represent 22k sale per (22m)once its all setup and sold . Company has projected an additional1m individuals to sign up this year alone for online medical records
MMR Information Systems, Inc. Taps Into Trillion Dollar Latino Market
http://finance.yahoo.com/news/MMR-Information-Systems-Inc-iw-1869373328.html?x=0&.v=1
Company still owns its bio tech assets it inherited through a reverse merger
140m was put into this tech and it went to stage 3 trials
MMR Information Systems and sanofi-aventis Enter Into Agreement Regarding Anti-CD20 Monoclonal Antibodies
http://finance.yahoo.com/news/MMR-Information-Systems-and-iw-3085022759.html?x=0&.v=1
MMRF a rare life changer stock Multi billion dollar company in the making. Exponential gains ahead. Currently near 50m cap. The very best management team I ever seen assembled in penny land. Revenues will be residual and represent organic
growth a cancellation rate of only 1%
They have developed the most advanced Electronic medical records tech in their peer group and are launching massive deals worldwide
From Microsoft’s top executive to NASA Administrator , Former House Minority Leader , Former Congressman, NASA Astronaut, political figures, and a CEO that’s a wealthy successful businessman that won white house humanitarian awards and took a 50m cap company to billion status before he resigned
MMRF has working partnerships and or agreements with Kodak, Unis China, Google Health, sanofi-aventis, Nihilent Technologies
MMRF Signs Global contract with Chartis who has 40m clients in 160 countries worldwide. MMRF tech will be embed in current policy holders they don’t have to sign up. CEO currently on a global trip launching the deal in many countries
http://finance.yahoo.com/news/MMR-Information-Systems-Inc-iw-2121287118.html?x=0&.v=1
MMRF predicted MMRPro implementation in China with Unis-Tonghe by 3rd quarter this year
http://ih.advfn.com/p.php?pid=nmona&article=40425772&symbol=USBB%3AMMRF
Chartis released this very same PR themselves
http://www.chartisinsurance.com/ncglobalweb/internet/US/en/files/PR_MMR_04-08-10_tcm295-255477.pdf
This one deal alone can be worth 100's of millions many more of its kind expected
MMRF negotiated a deal to buy 1000 scanners coming from Kodak which represent 22k sale per (22m)once its all setup and sold . Company has projected an additional1m individuals to sign up this year alone for online medical records
MMR Information Systems, Inc. Taps Into Trillion Dollar Latino Market
http://finance.yahoo.com/news/MMR-Information-Systems-Inc-iw-1869373328.html?x=0&.v=1
Company still owns its bio tech assets it inherited through a reverse merger
140m was put into this tech and it went to stage 3 trials
MMR Information Systems and sanofi-aventis Enter Into Agreement Regarding Anti-CD20 Monoclonal Antibodies
http://finance.yahoo.com/news/MMR-Information-Systems-and-iw-3085022759.html?x=0&.v=1
Great post, perfect short summary!
Is it OK for you if i repost this post on other boards
to spread the word about MMRF?
Threeflight, What do you think about MRNA?
I thought we had a solid base around 1.2-1.25
but it looks i was wrong!
Very well said,
It takes time to build a (multi)billion dollar company,
step by step but we will get their...
Tomorrow and the rest of the week will be very interesting to watch..
I still can't believe today's blog... UNREAL
What a day,
The MMR story is getting better and bigger everyday!
Only 6 minutes late our 15 minute meeting went the better part of an hour where I went through a comprehensive overview and demonstration of MMR’s personal health record and professional system. One never knows where an opportunity like this will lead. However I do believe that MMR has an opportunity to make a difference now that the office of the National Coordinator has seen what we do and the simple elegant way we do it. MMR now has a voice that has been heard and can continue to be heard in the most important office of health IT policy makers in the US government. Thank you Dick Gephardt
This is HUGE...
“Every person, all the events of your life, are there because you have drawn them there. What you choose to do with them is up to you.”
It is 6AM in Washington DC and I want to express how much I appreciate the support from all of you our employees, stakeholders and shareholders after yesterdays blog. It makes me especially good to know that many of you care as much about me personally and the schedule I keep as if we had been friends for a lifetime. So I am pleased to report that I did get 4 hours of sleep last night and I am raring to go today.
In yesterdays blog I wanted to make the point that “It’s never easy” and with hard work we will continue to move forward one step at a time towards a finish line that set as our own personal goal. And when you do that magical things happen.
If you haven’t ordered the book Illusions yet please do. There is another line in Illusions that reads……… “Every person, all the events of your life, are there because you have drawn them there. What you choose to do with them is up to you.”
Many of you ask about the involvement of MMR’s board of directors and advisors and if they are actively supporting my efforts on a day to day basis. The answer is that they are very involved and rarely does a day go by that I do not talk to at least two directors and at least one advisor.
When I travel Bobbie spends weeks (sometimes months) on advance work lining up meetings with every available minute of time. It’s a 24 hour a day tireless and thankless part of her job. Because I am in Washington DC we will reach out to advisors and directors former House Minority Leader Dick Gephardt, Former Congressman and Under secretary to the Department of Homeland Security Asa Hutchinson , and of course Former Administrator to the SBA Hector Barreto who I am actually here with.
These guys never say no and yesterday Dick Gephardt and Greg Carnrick working with Bobbie made the impossible “possible”. I have been trying to get MMR in front of the Obama administration particularly The Department of Health and Human Services and specifically in front of David Blumenthal the National Coordinator For Health information technology or better know as “The Man” in health IT circles. Although his office does not buy anything or endorse anything his office does set the agenda about the services and technologies that will define the next step to a digitized health system including the framework and shape of EMR’s and PHR’s to come.
As of yesterday morning May 4th at 6:30AM the answer for this trip was no way will it happen. Then about 30 minutes after I released my blog we were advised that I should be in his (Mr. Blumenthal’s) office at 3:45PM. (I never knew this meeting was coming.) That’s the good news. The bad news is I never got the message, nor did Bobbie, When I did finally did get the call and learned about the meeting now 90 minutes away I ran to the hotel, found my best suit and came downstairs to finish a meeting and television interview with a representative from Gannet and Channel 9. Ten minutes later I was told the meeting was cancelled because we never confirmed it. I told Bobbie that I would be standing by ready to go and essentially to “beg” to “make it happen” by getting me back on the calendar (not an easy task). At 3:12 I get the call to be at Health and Human Services in 13 minutes for a short meeting with the coordinator.
Only 6 minutes late our 15 minute meeting went the better part of an hour where I went through a comprehensive overview and demonstration of MMR’s personal health record and professional system. One never knows where an opportunity like this will lead. However I do believe that MMR has an opportunity to make a difference now that the office of the National Coordinator has seen what we do and the simple elegant way we do it. MMR now has a voice that has been heard and can continue to be heard in the most important office of health IT policy makers in the US government. Thank you Dick Gephardt
Robert H. “Bob” Lorsch, CEO,
MyMedicalRecords.com
www.mymedicalrecordsonline.com/videos
www.mymedicalrecords.com
Follow me on Twitter at PHREMRGURU
NEW BLOG UPDATE
http://blog.mymedicalrecordsinc.com/?p=97
Thanks for the update Bob,
keep up the good work!
More eyes are watching this one now,
I think we've got some big money moving in.
Great day all around.
More eyes are watching this one now!
I think we've got some big money moving in.
Looking very good.
Almost no sellers, shares are in strong hands...
The question you have to ask yourself is :
"Does Tom G. has any info to share?"
BLOG UPDATE
You are never given a wish without also being given the power to make it true, You may have to work for it, however………….
http://blog.mymedicalrecordsinc.com/?p=96
MMRF is the best long-term investment you will find on the OTC/Pinks. IMO
We have great products and an impressive management/Bod,
Mr Lorsch is building the company step by step
and i believe that he will make it a huge success .
The technology is there
but it takes quiet some time to implement a huge Project
like the Chartis deal.
Tulaz1, I really like your DD
and your vision about MMR's future
but concerning your revenue projections...
"Rome wasn't build in a day"
Thanks for this very interesting information
and this is just the beginnig...
That would be real nice...
i am happy if we could break through .001
That would be real nice...
i am happy if we could break through .001
What's the current L2?
thanks in advance
i will keep an eye on this one...
Their seems te be alot of "undiscovered" value in the Biotech Assets...
we need some news/update to make this run up..
thanks for this update
these figures makes me nuts...
a dream come true
I am planning to buy some more in the near future,
Our day will come sooner of later...
great close, interesting times ahead of us...
BLOG UPDATE
Greetings from the other side of the world.
Greetings from the other side of the world. Today will be the last day of the first work week of our Chartis International tour. Reception to MMR as an integrated policy benefit is very good. Today I have meetings scheduled at 2 locations about 150 miles apart. Doug Helm and I will meet with teams representing Singapore, Philippines, Hong Kong, Malaysia, Thailand, Indonesia, Australia, New Zealand and South Korea, to name a few. The good news about these types of trips is I never know when to be awake or when to sleep so that lets me work nearly 20 hours a day for you. Dubai was fascinating. Although my trip there was exploratory the potential for the region is very exciting. I was very impressed with the development and I saw more cranes in 1 day than I have ever seen in my life. Special thanks to our friends Sandi and Bruce Garrett at GRS. While I was traveling the company reached an agreement with sanofi-aventis through their good efforts. I hope to share more with you about the Chartis meetings as they develop. By the way, MMRPro is evolving faster than I am moving around the world. New features such as international outbound fax for ex-pats were added today and the ability to add patient calendar reminders will be added next month. Well its 4:30 AM and I a being picked up in 45 minutes so I have to sign off now.
Robert H. “Bob” Lorsch, CEO, MyMedicalRecords.com
http://blog.mymedicalrecordsinc.com/?p=70
MDRNA, Inc. Announces Patent Allowance Covering siRNA and Delivery Systems With Therapeutic Potential in Multiple Inflammatory
BOTHELL, WA -- (Marketwire)
04/19/10
MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced that the Intellectual Property Office of New Zealand (IPONZ) has issued a Notice of Acceptance for patent application 553828, titled "Methods of Treating an Inflammatory Disease by Double-Stranded Ribonucleic Acid." Allowed claims cover small interfering RNAs (siRNA) directed against the tumor necrosis factor (TNF) gene as well as several of the Company's key nucleic acid condensing and delivery peptide motifs in combination with a siRNA directed against TNF. This patent application was filed in 2005 as part of MDRNA's global intellectual property strategy which comprises a broad comprehensive patent portfolio protecting the Company's proprietary siRNA constructs, nucleic acid chemistry, nucleic acid delivery platforms, and its extensive library of siRNAs directed against therapeutic targets.
"The TNF family of cytokines includes some of the most validated targets in drug development and the ability to inhibit a specific member such as TNF-alpha remains a key therapeutic approach for many diseases," stated Barry Polisky, Chief Scientific Officer of MDRNA. "Highly potent siRNAs that inhibit TNF may have direct application in the treatment of inflammatory bowel disease, rheumatoid arthritis, psoriasis and other inflammatory conditions. Efficient delivery to specific cell types involved in these diseases is critical and the peptides protected under this patent provide a basis upon which we can modify our DiLA2 technology to specifically target TNF producing cells."
TNF-alpha (TNF-a) is the most studied member of the TNF family of cytokines. First described as a factor that causes necrosis (death) of tumor cells, subsequent research revealed TNF-a plays a key role within the immune system. TNF-a is produced by cells in blood and most tissues, and virtually all cells respond to TNF-a. It is the role that TNF-a plays in mediating chronic inflammatory diseases, such as rheumatoid arthritis, psoriasis, and Crohn's disease, that has been the focus of drug development efforts. Besides attaining blockbuster status in the treatment of rheumatoid arthritis, TNF inhibitors (e.g., Enbrel® and Remicade®) have revealed a potential role in multiple diseases. The ability to deliver a TNF-a siRNA to specific cells involved in inflammatory diseases and cancer provides a unique opportunity for an RNAi-based therapeutic.
"One of our main objectives in building an industry-leading RNAi company is to develop a patent portfolio that is both comprehensive and distinct from other RNAi companies," stated Mark Bales, Ph.D., Intellectual Property Counsel at MDRNA. "We believe this allowance demonstrates that MDRNA has a leading position in the field of RNAi therapeutics and that it is an excellent addition to our growing patent estate. We expect to receive additional similar allowances globally that will expand the breadth of our patent estate and further distinguish MDRNA as a leader in the RNAi field."
About MDRNA's Technology
MDRNA has a broad intellectual property estate that encompasses four key RNAi technology platforms: siRNA constructs, chemistry, nucleic acid delivery, and gene targets. The MDRNA-owned siRNA constructs and chemistry include its proprietary UsiRNA construct, which is a duplex siRNA chemically modified with non-nucleotide acyclic monomers (UNAs), and is distinct from the standard siRNA construct used by others in the industry. UsiRNAs are fully recognized by the RNAi machinery and provide for potent RNAi activity while specific placement of UNAs in a duplex siRNA minimizes potential off-target effects by the guide strand and reduces undesired passenger strand activity. Furthermore, UsiRNAs escape the surveillance mechanisms associated with cytokine induction, and provide protection from nuclease degradation.
The MDRNA delivery platforms include DiLA2 and nanoparticle forming peptides. DiLA2 is an MDRNA proprietary delivery platform of novel synthetic di-alklylated amino acid compounds used to make liposomal delivery formulations. The DiLA2 platform enables MDRNA to tailor the charge, linker and acyl chains of amino acids in order to configure liposomes for delivery to target tissues of interest. In addition, the platform is designed to permit attachment of various peptides and other targeting molecules to improve a variety of delivery characteristics. The MDRNA peptide nanoparticle platform includes exclusively in-licensed and developed IP surrounding the use of peptides for nanoparticle formulations that increase cellular uptake and endosomal release of siRNAs. MDRNA is currently biopanning its patented phage display library to identify additional peptides for targeted delivery, cellular uptake and endosomal release of siRNA.
MDRNA owns or controls 17 issued or allowed patents, and has 36 pending patent applications, 125 pending foreign patent applications and 7 PCT applications.
New facebook Message from Bob :
Its been a very busy 2 days re-organizing the Chartis launch travel schedule to fly around the Volcano. So we will start MMR's week off in Dubai where we plan on exploring strategic partner and licensing oppertunities on our way to worldwide Chartis meetings. Follow my blog at www.mymedicalrecords.com
it like it very much...
i really hope he keeps us up to date through his blog.
Much more deals to come in the (near) future...
It would be great if we could end this week in the green today
Damm, i missed the dip below 1.2
Facebook Message from Bob :
"Leaving tomorrow for 2 weeks of Chartis launch meetings and other opportunities for MMRGlobal. Only one hitch, working hard to get around Europe until the ash dissipates. I sure am happy that I have all my Emergency Travel info safely secured in my mymedicalrecords.com account."
it's looking better everyday...